Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J Merkt

Showing results (1-10 of 4) with videos related to

Pageof 1
Sort By:
Deutsche Medizinische Wochenschrift (1946)|April 18, 1997
[Hereditary hyperferritinemia-cataract syndrome]J Merkt
International Journal of Sports Medicine|May 1, 1981
Bioluminescent assay for determination of picomole amounts of AMP, ADP, and ATP in adipose and muscle tissue biopsiesM Feraudi, J Merkt, H Weicker
Respiration Physiology|June 1, 1983
Metabolic meaning of elevated levels of oxidative enzymes in high altitude adapted animals: an interpretive hypothesisP W Hochachka, C Stanley, J Merkt, et al.
Klinische Wochenschrift|July 2, 1984
Trial of sulfonylurea in combination with insulin in the therapy of diabetes type I and II. Evidence against a primary extrapancreatic receptor effectW P Bieger, R Dlugosch, A Rettenmeier, et al.
Pageof 1

Showing results (1-10 of 4) with videos related to

Sort By:
Pageof 1
Deutsche Medizinische Wochenschrift (1946)|April 18, 1997
[Hereditary hyperferritinemia-cataract syndrome]J Merkt
International Journal of Sports Medicine|May 1, 1981
Bioluminescent assay for determination of picomole amounts of AMP, ADP, and ATP in adipose and muscle tissue biopsiesM Feraudi, J Merkt, H Weicker
Respiration Physiology|June 1, 1983
Metabolic meaning of elevated levels of oxidative enzymes in high altitude adapted animals: an interpretive hypothesisP W Hochachka, C Stanley, J Merkt, et al.
Klinische Wochenschrift|July 2, 1984
Trial of sulfonylurea in combination with insulin in the therapy of diabetes type I and II. Evidence against a primary extrapancreatic receptor effectW P Bieger, R Dlugosch, A Rettenmeier, et al.
Pageof 1